Kiyokazu Takebayashi
Overview
Explore the profile of Kiyokazu Takebayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
848
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction
Usui N, Iwata K, Miyachi T, Takagai S, Wakusawa K, Nara T, et al.
EBioMedicine
. 2020 Aug;
58:102917.
PMID: 32739868
Background: Abnormalities of lipid metabolism contributing to the autism spectrum disorder (ASD) pathogenesis have been suggested, but the mechanisms are not fully understood. We aimed to characterize the lipid metabolism...
2.
Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, et al.
J Cereb Blood Flow Metab
. 2016 Apr;
37(3):877-889.
PMID: 27117856
The presence of activated microglia in the brains of healthy elderly people is a matter of debate. We aimed to clarify the degree of microglial activation in aging and dementia...
3.
Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, et al.
JAMA Psychiatry
. 2013 Feb;
70(1):49-58.
PMID: 23404112
Context: A growing body of evidence suggests that aberrant immunologic systems underlie the pathophysiologic characteristics of autism spectrum disorder (ASD). However, to our knowledge, no information is available on the...
4.
Kikuchi M, Hirosawa T, Yokokura M, Yagi S, Mori N, Yoshikawa E, et al.
J Neurosci
. 2011 Aug;
31(31):11193-9.
PMID: 21813680
Brain β-amyloid (Aβ) deposition during normal aging is highlighted as an initial pathogenetic event in the development of Alzheimer's disease. Many recent brain imaging studies have focused on areas deactivated...
5.
Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, et al.
PLoS One
. 2011 Jun;
6(5):e20470.
PMID: 21647375
Background: Accumulating evidence suggests that dysregulation of the immune system is involved in the pathophysiology of autism spectrum disorders (ASD). The aim of the study was to explore immunological markers...
6.
Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders
Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Tsujii M, Futatsubashi M, et al.
Arch Gen Psychiatry
. 2011 Mar;
68(3):306-13.
PMID: 21383265
Context: Both neuropsychological and functional magnetic resonance imaging studies have shown deficiencies in face perception in subjects with autism spectrum disorders (ASD). The fusiform gyrus has been regarded as the...
7.
Nakamura K, Iwata Y, Anitha A, Miyachi T, Toyota T, Yamada S, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2010 Dec;
35(2):454-8.
PMID: 21118708
Autism is a pervasive developmental disorder diagnosed in early childhood. Abnormalities of serotonergic neurotransmission have been reported in autism. Serotonin transporter (5-HTT), which modulates serotonin levels, is a major therapeutic...
8.
Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, et al.
Eur J Nucl Med Mol Imaging
. 2010 Sep;
38(2):343-51.
PMID: 20844871
Purpose: Amyloid β protein (Aβ) is known as a pathological substance in Alzheimer's disease (AD) and is assumed to coexist with a degree of activated microglia in the brain. However,...
9.
Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, et al.
Neurosci Res
. 2010 Jul;
68(2):137-41.
PMID: 20615438
MET receptor tyrosine kinase (MET)-mediated signaling has been implicated in multiple aspects of neocortical and cerebellar neuronal growth and maturation. A promoter functional SNP (rs1858830) that disrupts the transcription of...
10.
Iwata Y, Yamada K, Iwayama Y, Anitha A, Thanseem I, Toyota T, et al.
Am J Med Genet B Neuropsychiatr Genet
. 2010 May;
153B(6):1221-7.
PMID: 20468077
The FXYD domain-containing ion transport regulator 6 (FXYD6) gene encodes phosphohippolin that regulates cellular ion transport by altering the kinetic properties of Na,K-ATPase. Phosphohippolin is highly expressed in brain regions...